Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

weight-2036971_960_720

UK rates of obesity increased by 92% over two decades

November 13, 2017 Research and Development, Sales and Marketing OECD, biotech, drugs, obesity, pharma, pharmaceutical

A recent report by the OECD shares concerns that the UK’s overall health looks set to face a crisis due …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmafile, top ten

Friday again, and we bring you the most read articles on our site this week – one of which was …
News
shutterstock_187433765

Breast cancer recurrence can occur up to 20 years after treatment, report shows

November 10, 2017 Medical Communications, Research and Development Cancer, breast cancer, pharma, tamoxifen

New findings from the Early Breast Cancer Trialists’ Collaborative Group have demonstrated that oestrogen receptor-positive (ER-positive) breast cancer is able …
News
child-2916844_960_720

Sage scores good but not great P3 postpartum depression drug results

November 10, 2017 Medical Communications, Research and Development Sage Therapeutics, biotech, drugs, pharma, pharmaceutical

Sage Therapeutics share price soared 50% on the release that its two Phase 3 trials of brexanolone showed statistically significant …
News

Recipharm Interim report January – September 2017

November 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Interim report January – September 2017 July – September 2017    
News
Press release

Recipharm to end operations in two facilities in Sweden

November 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm today announces that it will initiate a process with the intention of discontinuing manufacturing operations at its facilities in …
News
Press release
skin-222664_960_720

Gene therapy helps child regrow 80% of skin

November 9, 2017 Medical Communications, Research and Development biotech, drugs, gene therapy, pharma, pharmaceutical, stem cell

A young child has been brought back from the verge of death after an experimental combination of stem cell and …
News
shutterstock_206748499

17,000 English patients are surviving Stage 4 cancer for two years or more, new data shows

November 8, 2017 Research and Development Cancer, bladder cancer, breast cancer, colon cancer, lung cancer, pharma, prostate cancer

At least 17,000 people in the UK are living with Stage 4 cancer and have survived for two years or …
News
promotional_banner

The End Game: Payer Engagement Webinar

November 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, pharma, pharmaceutical

In our latest free to attend webinar, we have joined up with NDA to bring you the latest market access …
News
cellectis

Cellectis given another shot at off-the-shelf CAR-T

November 8, 2017 Medical Communications, Research and Development CAR-T, biotech, cellectis, drugs, pharma, pharmaceutical

It is easy to forget the very real dangers that CAR-T treatment present to patients after Novartis and Gilead both …
News
doctor_notes

Clinical trials still have a problem with ethnic minorities

November 8, 2017 Medical Communications, Research and Development biotech, clinical trials, drugs, ethnic minorities, pharma, pharmaceutical

Research, published in the Journal of Women’s Health, that aimed to determine the effects of the FDA’s guidance on the …
News
novartis_outside_1

Novartis’ Kisqali smashes Phase 3 primary endpoint in breast cancer for second time

November 8, 2017 Research and Development Cancer, Kisqali, Novartis, breast cancer, pharma

Novartis has revealed that its immunotherapy drug Kisqali (ribociclib) met its primary endpoint of progression-free survival in its second Phase …
News
online_survey_icon_or_logo_v2

Collaboration in Biopharma

November 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dear Colleague,
News
mosquito

Breathalyser for malaria shows promise in trials

November 7, 2017 Manufacturing and Production, Research and Development biotech, drugs, malaria, pharma, pharmaceutical

Access to sophisticated rapid blood tests for malaria has improved dramatically in recent years but there are still issues in …
News
window-2387518_960_720

Clinical trial transparency: Letting the light in

November 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, clinical trial transparency, clinical trials, drugs, pharma, pharmaceutical

Transparency is one of those words for which the exact meaning has become clouded by murkier connotations. The chances are …
Feature
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026